Germ cell neoplasia in situ (GCNIS) represents the precursor lesion for many types of testiculargerm cell tumors.[1]
The term GCNIS was introduced with the 2016 edition of the WHO classification of urological tumours.[1] GCNIS more accurate describes the lesion as it arises between the basement membrane and Sertoli cells (the cells that 'nurse' the developing germ cell). The common, unspecified variant of the entity was once considered to be a carcinoma in situ,[2] although the term "carcinoma in situ" is now largely historical as it is not an accurate description of the process.[3]
Pediatric Yolk sac tumors (endodermal sinus tumour).[6] This is currently an area of controversy as some authors dispute the absence of ITGCN in these cases.[3]
GCNIS is not palpable, and not visible on macroscopic examination of testicular tissue. Microscopic examination of affected testicular tissue most commonly shows germ cells with enlarged hyperchromatic nuclei with prominent nucleoli and clear cytoplasm. These cells are typically arranged along the basement membrane of the tubule, and mitotic figures are frequently seen. The sertoli cells are pushed toward the lumen by the neoplastic germ cells, and spermatogenesis is almost always absent in the affected tubules. Pagetoid spread of GCNIS into the rete testis is common. Immunostaining with placental alkaline phosphatase (PLAP) highlights GCNIS cell membranes in 95 percent of cases. OCT3/4 is a sensitive and specific nuclear stain of GCNIS.[3]
Treatment
GCNIS is generally treated by radiation therapy and/or orchiectomy. Chemotherapy used for metastatic germ cell tumours may also eradicate GCNIS.[3]
^Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A. (Eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System
and Male Genital Organs. IARC Press: Lyon 2004. ISBN92-832-2412-4